Aspen Neuroscience Completes Phase 1/2a ASPIRO Trial Cohort Three Dosing and State-of-the-Art Manufacturing Expansion, Paving the Way for Developing Transformative Therapies ...

ASPIRO is the first multi-patient, multi-center clinical trial of an autologous cell therapy for Parkinson's disease. It is evaluating safety, tolerability, and preliminary efficacy of ANPD001 in ...
Scientific Research Publishing

Spatiotemporal Evolution Patterns and Intelligent Forecasting of Passenger Flow in Megacity High-Speed Rail Hubs: A Case Study of Guangzhou South Railway Station ()

Spatiotemporal Evolution Patterns and Intelligent Forecasting of Passenger Flow in Megacity High-Speed Rail Hubs: A Case ...